Tag Archives: ataluren

Testing if drugs can improve cornea regeneration

By researcher Martin Collinson Aniridia, caused by mutation in the so-called eye ‘master regulator gene’, PAX6, can impact on vision in several ways. In addition to the absence or near-absence of the iris, people with aniridia are at high risk … Continue reading

Rate this:

Posted in Research | Tagged , , | Leave a comment

£200,000 aniridia drug research, based and funded in the UK underway

Research into the growth of eyes with aniridia has begun, funded by Aniridia Network and two families in the UK. In 2018, for the first time, Aniridia Network excitedly partnered with Fight for Sight to offer a £15,000 grant for … Continue reading

Rate this:

Posted in ANUK news, Medical staff talking, Research | Tagged , , , , , , , , | 2 Comments

Drug company donates £1,000 to ANUK

A global biopharmaceutical company has provided a donation to ANUK for which we are extremely grateful. PTC Therapeutics is the company that discovered and is developing ataluren for the treatment of disorders due to a genetic nonsense mutation. Approximately 20% of patients … Continue reading

Rate this:

Posted in ANUK news, Fundraising, Research | Tagged , , , | Leave a comment

Cure for aniridia under spotlight

A new study has suggested potential eyedrop therapy for aniridia. Is the hype justified and what are the details? Aniridia is a genetic abnormality caused by mutations in the so-called ‘Master Regulator’ gene for eye development, PAX6.  Because PAX6 is … Continue reading

Rate this:

Posted in Medical staff talking, Research | Tagged , , , | 11 Comments